Previous 10 | Next 10 |
home / stock / medif / medif news
A long-term view is essential to successful cannabis investing. A long-term view requires a long-term plan. A long-term plan is an effective way to deal with the doubts, questions and uncertainty that cannabis investors may be experiencing. My five year cannabis investing plan...
MediPharm Labs (OTCQX:MEDIF) completed a US FDA Drug Master File (DMF) for pure natural CBD Active Pharmaceutical Ingredient (API). DMFs consists of detailed information about manufacturing, processes, packaging, and stability of APIs to be used in medicinal products for human use. ...
MediPharm Labs Enters United States Pharmaceutical Market with Submission of FDA DMF Canada NewsWire Completed a Drug Master File ("DMF") process for CBD Active Pharmaceutical Ingredient ("API") for the US Federal Drug Administration ("FDA"). Use of Canadian Dr...
TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce that it has completed all payme...
MediPharm Labs pharma-quality CBD dominant oil line has been awarded CBD Brand of the year by KIND Magazine. MediPharm Labs’ CBD products have seen steady revenue growth and notoriety in 2021, including on national television on an episode of CBC Marketplace. BARRIE, Onta...
Strong cash balance and continued reduction of convertible debt to less than $500K. Opportunities for optimization of the operating strategy between Australia and Canada as the Canadian Drug Establishment Licence (DEL) unlocks many manufacturing and supply chain pathways. These pathwa...
BARRIE, Ontario, Dec. 07, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce changes to its Board...
Patient based delivery of medical cannabis executed with approval from both Barbados and Canadian Health Authorities. This marks the fourth new country entered by MediPharm Labs in 2021, following initial shipments to Germany, Brazil and Peru. BARRIE, Ontario, Nov. 26, 2021 (G...
MediPharm Labs (OTCQX:MEDIF) announces the expansion of its unique cannabinol (CBN) product line. These new products are the latest being launched after the success of the Company’s CBN:THC Nighttime Formula and Northbound High CBN vape cartridge launched in Q2 2021. CBN is typically f...
A leader in CBN products, MediPharm Labs, adds CBN:CBD products to its wellness portfolio for consumers and patients looking for a product without THC effects. New CBN products include CBN:CBD 1:2 Relax Formula Oil and a Northbound high CBN and high CBD vape cartridge. BARRIE, O...
News, Short Squeeze, Breakout and More Instantly...
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders Canada NewsWire TORONTO , June 26, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical comp...
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols Canada NewsWire MediPharm has licenced global manufacturing, distribution, and sales rights of the novel advanced medical cannabis technology from Remidose Aerosols. Product...